Primary Record
aplaviroc
- In stock
- 6,877 g
- Purity
- 98.1 %
- CAS
- 461443-59-4
Compound Identifiers & Properties
- CAS
- 461443-59-4
- PubChem CID
- 3001322
- SMILES
- CCCCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)[C@@H](C5CCCCC5)O
- Canonical SMILES
- CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2
Names & Synonyms
- aplaviroc
- aplavirocum
- Aplaviroc [INN]
- Aplaviroc HCl
- PG9-apl conjugate
- 873140 Compound
- 461443-59-4
- AK-602
- Aplaviroc hydrochloride
- AC1MHDOS
- GW873140
- CD4-IgG-apl conjugate
- mAB b12-apl conjugate
- APLAVIROC [MI]
- RefChem:113420
- mAb 2G12-apl conjugate
- mAB PG16-apl conjugate
- AK 602
- D0G6SZ
- APLAVIROC [WHO-DD]
- AK602
- CD4-IgG aplaviroc conjugate
- mAB PG9-aplaviroc conjugate
- DTXSID6047317
- GTPL805
- UNII-98B425P30V
- ONO 4128
- Trastuzumab-aplaviroc conjugate
- Aplaviroc hydrochloride (USAN)
- GW 873140
- orb1707646
- SCHEMBL4577096
- 98B425P30V
- CHEMBL1255794
- CHEMBL1668019
- DTXCID4027317
- GSK-873140
- ONO-4128
- b12 antibody-aplaviroc conjugate
- GW-873140
- GSK873140
- PG16 antibody-aplaviroc conjugate
- 2G12 antibody-aplaviroc conjugate
- C33H43N3O6
- BCP22462
- BDBM50336345
- GSK-87314
- GW873140A
- AKOS040741156
- C33-H43-N3-O6
- CID3001322
- DB06497
- CID:3001322
- NCGC00247933-01
- AC-31372
- BA166505
- DA-61166
- HY-17450
- SID:318165603
- 2-imidazo[1,2-a]pyrimidin-7-ylpropan-2-ol
- CS-0008289
- J2.241.522K
- Trastuzumab antibody conjugated with aplaviroc
- A13471
- C499671
- AK 602;GSK 873140;GW 873140
- Q4779956
- 3-(ethoxycarbonyl)-5-(pyrid-2'-yl)-1,2,4-triazole
- Benzoic acid, 4-(4-(((3R)-1-butyl-3-((R)-cyclohexylhydroxymethyl)-2,5-dioxo-1,4,9-triazaspiro(55)undec-9-yl)methyl)phenoxy)-
- 4-[4-[[(3R)-1-butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid
- 4-[4-[[(9R)-11-butyl-9-[(R)-cyclohexyl(hydroxy)methyl]-7,10-dioxo-3,8,11-triazaspiro[5.5]undecan-3-yl]methyl]phenoxy]benzoic acid
- 4-((4-(((3R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methyl)-2,5-dioxo-1,4,9-triazaspiro(5.5)undec-9-yl)methyl)phenyl)oxy)benzoic acid hydrochloride
- 4-(4-(((R)-1-Butyl-3-((R)-cyclohexyl(hydroxy)methyl)-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl)methyl)phenoxy)benzoic acid
- 4-(4-(((3R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methyl)-2,5-dioxo-1,4,9-triazaspiro(5.5)undecan-9-yl)methyl)phenoxy)benzoic acid
- 4-(4-(((3R)-1-butyl-3-((R)-cyclohexyl-hydroxymethyl)-2,5-dioxo-1,4,9-triazaspiro(5.5)undecan-9-yl)methyl)phenoxy)benzoic acid
- 4-(4-(((3R)-1-butyl-3-((R)-cyclohexylhydroxymethyl)-2,5-dioxo-1,4,9-triazaspiro(5.5)undecan-9-yl)methyl)phenoxy)benzoic acid
- 4-(4-(((R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methyl)-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl)methyl)phenoxy)benzoic acid hydrochloride
- 4-(4-{[(3R)-1-butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl}phenoxy)benzoic acid
- 4-[4-({(3R)-1-Butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl}methyl)phenoxy]benzoic acid
- 4-[4-({1-butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undec-9-yl}methyl)phenoxy]benzoic acid
- 4-[4-[[(3R)-1-butyl-3-[(R)-cyclohexyl-hydroxymethyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid
- 4-[4-[[(5R)-1-Butyl-5-[(R)-cyclohexyl(hydroxy)methyl]-3,6-dioxospiro[piperazine-2,4 -piperidine]]-1 -ylmethyl]phenoxy]benzoic acid
- 4-[4-[[(9R)-11-butyl-9-[(R)-cyclohexyl(hydroxy)methyl]-7,10-dioxo-3,8,11-triazaspiro[5.5]undecan-3-yl]methyl]phenoxy]benzoic acid hydrochloride
- 461445-21-6
- 461451-35-4
- 674782-28-6
- 675184-11-9
- benzoic acid, 4-(4-(((3R)-1-butyl-3-((R)-cyclohexylhydroxymethyl)-2,5-dioxo-1,4,9- triazaspiro(55)undec-9-yl)methyl)phenoxy)-
- Benzoic acid, 4-[4-[[1-butyl-3-[(R)-cyclohexylhydroxymethyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undec-9-yl]methyl]phenoxy]-
- Benzoic acid, 4-[4-[[1-butyl-3-[(R)-cyclohexylhydroxymethyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undec-9-yl]methyl]phenoxy]- & Soluble CD4
- Benzoic acid, 4-[4-[[1-butyl-3-[(R)-cyclohexylhydroxymethyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undec-9-yl]methyl]phenoxy]-& Soluble CD4
- rac-4-(4-((1-butyl-3-(cyclohexyl(hydroxy)methyl)-2,5-dioxo-1,4,9-triazaspiro(5.5)undec-9-yl)methyl)phenoxy)benzoic acid